查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1678795

全球造口護理設備市場 - 2025 年至 2033 年

Global Ostomy Care Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球造口護理設備市場規模達到 35.4 億美元，預計到 2033 年將達到 75.1 億美元，在 2025-2033 年預測期內的複合年成長率為 7.8%。

造口護理設備是用於協助個人進行造口手術（例如結腸造口術、迴腸造口術或泌尿道造口術）的醫療產品，處理廢物並確保患者舒適。技術、氣味控制、防洩漏和親膚材料的進步提高了患者的生活品質。造口護理設備市場涵蓋為接受造口手術的個人提供支援的產品的生產、分銷和銷售。

造口術是透過手術將消化系統或泌尿系統的一部分轉移到身體的外部開口，即所謂的造口。此手術通常用於治療大腸直腸癌、發炎性腸道疾病（如克隆氏症和潰瘍性結腸炎）、膀胱癌和某些先天性疾病等患者。

市場動態：

促進因素與約束因素

發炎性腸道疾病率上升

由於克隆氏症和潰瘍性結腸炎等發炎性腸道疾病 (IBD) 的增多，全球造口護理設備市場正在蓬勃發展。這些慢性病通常需要手術干預，從而導致對造口護理產品的需求增加。 IBD 發生率不斷上升，尤其是在已開發國家，原因在於飲食習慣的改變、壓力和遺傳傾向。

例如，2024 年的一項研究估計，23.9 億美國人患有 IBD，其中 125 萬人患有潰瘍性結腸炎，101 萬人患有克隆氏症。北美是發炎性腸道疾病發生率最高的地區，美國每 10 萬人每年有 721 例。潰瘍性結腸炎的盛行率高於克隆氏症，但克隆氏症在10歲以下兒童中更為常見。

IBD 的發生率不斷上升，影響了 239 萬美國人，這推動了對造口護理設備的需求，特別是在發病率最高的北美地區，從而導致先進的造口產品和配件的市場顯著成長。

高成本和有限的報銷政策

造口護理設備的需求不斷增加，但產品成本高和報銷政策不充分阻礙了市場成長。患者，特別是中低收入國家的患者，在取得先進的造口產品時面臨經濟障礙。袋子和配件的經常性費用進一步加重了患者的負擔，降低了採用率。醫療保健系統的報銷政策因地區而異，進一步影響了負擔能力。這些挑戰阻礙了造口護理設備的廣泛普及，尤其是在服務不足的市場。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 發炎性腸道疾病率上升
      • 已開發市場優惠的報銷政策
    • 限制
      • 高成本和有限的報銷政策
      • 嚴格的監管要求
    • 機會
      • 拓展新興市場
    • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 管道分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：依產品類型

  • 造口袋
  • 一體式系統
  • 兩件式系統
  • 配件
  • 造口粉
  • 黏合劑和密封劑
  • 造口糊劑
  • 其他

第 7 章：按應用

  • 結腸造口術
  • 迴腸造口術
  • 尿路造口術
  • 其他

第 8 章：按最終用戶

  • 醫院
  • 門診手術中心 (ASC)
  • 家庭護理設置

第9章：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • Coloplast A/S
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Hollister Incorporated
  • ConvaTec Group PLC
  • B. Braun Melsungen AG
  • 3M Company
  • Welland Medical Limited
  • Salts Healthcare Ltd
  • Torbot Group Inc
  • Byram Healthcare
  • Sarasota Medical Products
  • Similar data will be provided for each market player.
  • 馬倫製造與開發公司
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • Cymed 造口公司
  • Schena 造口技術有限公司
  • 阿爾卡雷有限公司
  • 將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄
Product Code: MD9290

The global ostomy care devices market reached US$ 3.54 billion in 2024 and is expected to reach US$ 7.51 billion by 2033, growing at a CAGR of 7.8% during the forecast period 2025-2033.

Ostomy care devices are medical products used to assist individuals with ostomy surgery, such as colostomy, ileostomy, or urostomy, managing waste and ensuring patient comfort. Advancements in technology, odor control, leak prevention, and skin-friendly materials enhance patient quality of life. The ostomy care devices market encompasses the production, distribution, and sale of products designed to support individuals who have undergone an ostomy procedure.

An ostomy involves surgically diverting part of the digestive or urinary system to an external opening on the body, known as a stoma. This procedure is commonly performed for patients dealing with conditions such as colorectal cancer, inflammatory bowel diseases (like Crohn's disease and ulcerative colitis), bladder cancer, and certain congenital disorders.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Inflammatory Bowel Diseases

The global ostomy care devices market is booming due to the rise in inflammatory bowel diseases (IBD), such as Crohn's and ulcerative colitis. These chronic conditions often require surgical interventions, leading to increased demand for ostomy care products. The growing incidence of IBD, particularly in developed countries, is attributed to changing dietary habits, stress, and genetic predispositions.

For instance, A 2024 study estimated that 2.39 Billion Americans have IBD, including 1.25 million with ulcerative colitis and 1.01 million with Crohn's disease. The highest rates of IBD are in North America, with 721 cases per 100,000 person-years in the US. The prevalence of ulcerative colitis is higher than Crohn's disease, but Crohn's disease is more prevalent among children under 10 years.

The increasing prevalence of IBD, affecting 2.39 million Americans, drives demand for ostomy care devices, particularly in North America, where the region has the highest rates, resulting in significant market growth for advanced ostomy products and accessories.

High Cost and Limited Reimbursement Policies

The demand for ostomy care devices is increasing, but high product costs and inadequate reimbursement policies hinder market growth. Patients, particularly in low- and middle-income countries, face financial barriers to access advanced ostomy products. Recurring costs of pouches and accessories further burden patients, reducing adoption rates. Healthcare systems' reimbursement policies vary across regions, further affecting affordability. These challenges hinder widespread accessibility of ostomy care devices, especially in underserved markets.

Segment Analysis

The global ostomy care devices market is segmented based on product type, application, end user and region.

Product Type:

Ostomy bags segment is expected to dominate the ostomy care devices with the highest market share

Ostomy bags are medical devices used to collect waste from the abdomen after a surgical procedure, particularly for individuals with gastrointestinal disorders like IBD or colorectal cancer. They come in one-piece and two-piece systems, with modern designs enhancing comfort and hygienic waste management, improving patient quality of life.

The ostomy bags segment is the top choice in the global ostomy care devices market due to their crucial role in waste management for individuals undergoing ostomy procedures. Unlike other accessories, ostomy bags are a primary necessity for patients, making them the most in-demand product category. They come in one-piece and two-piece systems, with one-piece systems being preferred for simplicity and ease of use, while two-piece systems offer flexibility and longer wear time.

Geographical Analysis

North America is expected to hold a significant position in the ostomy care devices market share

North America holds a substantial position in the ostomy care devices market and is expected to hold most of the market due to significant product launches, rising prevalence of IBD, colorectal cancer, and other gastrointestinal disorders. The region's healthcare infrastructure, key players, continuous product innovations, and favourable reimbursement policies drive market growth. The aging population fuels demand for high-quality ostomy bags and accessories.

For instance, in April 2024, Convatec launched Esteem Body with Leak Defense in the US, addressing the growing use of soft convexity ostomy barriers due to global obesity, which has nearly tripled since 1975. This trend has led to changes in abdominal topography and challenges in ostomy care management.

Hence, Convatec's launch of Esteem Body with Leak Defense in April 2024 enhances the ostomy care market by addressing the rising demand for soft convexity ostomy barriers, driven by increasing obesity rates. This innovation improves patient comfort and leak prevention, fostering market growth through higher adoption and advanced ostomy care solutions.

Competitive Landscape

The major global players in the ostomy care devices market include Coloplast A/S, Hollister Incorporated, ConvaTec Group PLC, B. Braun Melsungen AG, 3M Company, Welland Medical Limited, Salts Healthcare Ltd, Torbot Group Inc., Byram Healthcare and Sarasota Medical Products among others.

Key Developments

  • In July 2024, Revel, a leading ostomy care brand, introduced its first product, It's in the Bag, a deodorizing lubricant developed using LiquiGlide, an MIT-engineered technology. This product offers durable, self-lubricating, slippery surfaces and sets category-leading laboratory testing benchmarks, aiming to improve quality-of-life for ostomates.
  • In May 2024, Coloplast received reimbursement approval for the world's first digital leakage notification system, Heylo, and expanded its SenSura Mio ostomy range with two new products. The company's 2025 strategy, Strive25, aims to raise the standard of care for users and bring new products to market at a higher pace. Heylo detects potential leakages under the ostomy baseplate, notifying users at an early stage to prevent leakage progression.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing product launches and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

The global ostomy care devices market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Inflammatory Bowel Diseases
      • 4.1.1.2. Favorable Reimbursement Policies in Developed Markets
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost and Limited Reimbursement Policies
      • 4.1.2.2. Stringent Regulatory Requirements
    • 4.1.3. Opportunity
      • 4.1.3.1. Expansion into Emerging Markets
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with the largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Pipeline Analysis
  • 5.8. Supply Chain Analysis
  • 5.9. Patent Analysis
  • 5.10. SWOT Analysis
  • 5.11. Unmet Needs and Gaps
  • 5.12. Recommended Strategies for Market Entry and Expansion
  • 5.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.14. Pricing Analysis and Price Dynamics
  • 5.15. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Ostomy Bags*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. One-piece Systems
  • 6.4. Two-piece Systems
  • 6.5. Accessories
  • 6.6. Stoma Powder
  • 6.7. Adhesives and Sealants
  • 6.8. Stoma Paste
  • 6.9. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Colostomy*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ileostomy
  • 7.4. Urostomy
  • 7.5. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers (ASCs)
  • 8.4. Home Care Settings

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Mexico
      • 9.4.6.2. Brazil
      • 9.4.6.3. Argentina
      • 9.4.6.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Coloplast A/S*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Hollister Incorporated
  • 11.3. ConvaTec Group PLC
  • 11.4. B. Braun Melsungen AG
  • 11.5. 3M Company
  • 11.6. Welland Medical Limited
  • 11.7. Salts Healthcare Ltd
  • 11.8. Torbot Group Inc
  • 11.9. Byram Healthcare
  • 11.10. Sarasota Medical Products
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. Marlen Manufacturing & Development Co*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Cymed Ostomy Co.
  • 11.13. Schena Ostomy Technologies, Inc.
  • 11.14. Alcare Co., Ltd.
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us